FDA approves Alhemo® injection as once-daily prophylactic treatment to prevent or reduce the frequency of bleeding episodes for adults and children 12 years of age and older with hemophilia A or B with inhibitors ...Middle East

FDA approval is based on data from the pivotal phase 3 trial (explorer7) establishing the safety and efficacy of Alhemo® for daily prevention of bleeds in adults and pediatric patients 12 years of age and older living with hemophilia A or B with inhibitors Results from the pivotal trial...

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA approves Alhemo® injection as once-daily prophylactic treatment to prevent or reduce the frequency of bleeding episodes for adults and children 12 years of age and older with hemophilia A or B with inhibitors )

Also on site :

• Tears and Shock: First Islander Sent Home on ‘Love Island USA’ Season 7
• A Gaza-bound aid boat carrying Greta Thunberg and other activists has been diverted to Israel
• 'Hamilton’ Original Cast Reunites at 2025 Tony Awards & Fans Are Saying the Same Thing